drugset / Trial / NCT02534961
Prophylactic Antibiotics Before RFA for HCC
Phase 4
Unknown
600 enrolled
Taipei Veterans General Hospital, Taiwan
Taipei Medical University Hospital · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This randomized prospective study aims to investigate whether prophylactic administration of antibiotics has an influence on inflammatory markers, liver function test results, or the incidence of post-procedural infection in patients with hepatocellular carcinoma (HCC) undergoing radiofrequency ablation (RFA).
Timeline
- Start
- 2015-01
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cefazolin | Small molecule | 2 g | Intravenous |
| Comparator | Cefazolin | Small molecule | 3 g | Intravenous |